During the past decade, Stanza Clinical Research Centre : Mamelodi conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 8 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stanza Clinical Research Centre : Mamelodi" #1 sponsor was "Allergan" with 4 trials, followed by "Janssen Vaccines & Prevention B.V." with 4 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stanza Clinical Research Centre : Mamelodi" #1 collaborator was "Bio Analytical Research Corporation" with 1 trials as a collaborator, "BioVac" with 1 trials as a collaborator, "Biocair" with 1 trials as a collaborator, "Clinical Laboratory Services" with 1 trials as a collaborator and "Dis-Chem Pharmacy" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Stanza Clinical Research Centre : Mamelodi" are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "COVID-19 Prevention" (1 trials), "Depressive Disorder, Major" (1 trials) and "HIV-1" (1 trials). Many other conditions were trialed in "Stanza Clinical Research Centre : Mamelodi" in a lesser frequency.

Most popular intervention types in "Stanza Clinical Research Centre : Mamelodi" are "Drug" (7 trials), "Biological" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Relamorelin" (3 trials), "Ad26.COV2.S" (2 trials), "Ad26.Mos4.HIV" (1 trials) and "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stanza Clinical Research Centre : Mamelodi" are 10 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Stanza Clinical Research Centre : Mamelodi". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Stanza Clinical Research Centre : Mamelodi, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Stanza Clinical Research Centre : Mamelodi, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".